Investigation on quantitatıve structure-activity relationshıps of benzoylamino benzoic acıd derivatives as β-ketoacyl-acyl carrıer protein synthase ııı (fabh) inhibitors by Subramani, pp et al.
631
RESEARCH PAPER
Marmara Pharmaceutical Journal 21/3: 631-643, 2017
DOI: 10.12991/marupj.323292
PP Subramani, SV Khare, SP Choudhari, SP Phalle, SS Kumbhar, 
VS Kavade, PB Choudhari
Department of Pharmaceutical Chemistry, Bharati Vidyapeeth College of 
Pharmacy, Kolhapur, Maharashtra
AA Pratavale
Department of Chemistry, Shivaji University, Kolhapur
Corresponding Author:
P. B Choudhari
e-mail: prafulla.choudhari@bharatividyapeeth.edu, praffula12@gmail.com
Submitted / Gönderilme: 02.02.2017 Revised / Düzeltme: 22.03.2017
Accepted / Kabul: 04.05.2017
PP Subramani, SV Khare, SP Choudhari, SP Phalle, SS Kumbhar, VS Kavade, AA Pratavale, PB Choudhari
models were developed with good cross-validated correlation 
coefficient and external validation values. Developed QSAR 
model indicated the significance of the lipophilic parameters 
in an inhibitory potential of benzoyl amino benzoic acid 
derivatives.
Keywords: QSAR, Benzoyl amino benzoic acid, FabHβ-
Ketoacyl-acyl Carrier Protein Synthase III, Partial least square 
(PLS), Multiple linear regression (MLR).
ABSTRACT
Fatty acid biosynthesis is an important process in the 
microorganism life cycle. β-Ketoacyl-acyl Carrier Protein 
Synthase III (FABH) catalyzes a critical step in fatty acid 
biosynthesis via type ii fatty acid biosynthesis. Series of 43 
Benzoyl amino benzoic acid derivatives were subjected to 2D 
and 3D quantitative structure-activity relationships (QSAR) 
analysis via multiple linear regression and partial least square 
analysis respectively. Statistically significant four QSAR 
Investigation on quantitative structure-activity relationships of 
benzoylamino benzoic acid derivatives as β-ketoacyl-acyl carrier protein 
synthase III (FABH) inhibitors
Introduction:
Tuberculosis (TB) is the most common infectious and lethal 
disease known to human. In recent decade mortality rate 
of tuberculosis is increased rapidly in developing countries 
[1]. In 1993, World Health Organization noted tuberculosis 
as a global emergency The problem of the tuberculosis is 
further aggravated by the emergence of the resistant form 
of tuberculosis like MDR, XDR, and TDR Association of 
tuberculosis with HIV-1 and 2 infections are major factors 
in the actual resurgence of tuberculosis. Development of the 
newer antitubercular agents targeting conservative pathways 
now becomes need of time in the current scenario [1-5]. One 
of the important strategies which are currently employed is 
to develop inhibitors of mycobacterial cell wall biosynthesis. 
The cell wall of the M. tuberculosis contributes significantly 
towards resistance to most commonly-used antibiotics and 
chemotherapeutic agents. The cell wall of the mycobacteria 
is made up of three major components macromolecules, 
peptidoglycan, arabinogalactan and mycolic acids which were 
covalent bound with each other [6-8]. Fatty acid biosynthesis is 
an important step in the cell wall generation in mycobacteria, 
it has been established that this fatty acid biosynthesis process 
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may become the source of utilizable molecular targets due its 
non-homologous nature to mammalian system. Mycobacteria 
possess both a type I and type II fatty acid synthase in which 
type I fatty acid synthase is responsible for the formation of 16-
24 carbon length fatty acids, which are then elongated to form 
long chain high molecular mass mycolate. Bacterial 3-Ketoacyl 
Acyl Carrier Protein Synthase III (FabH) is a key enzyme plays 
important role in fatty acid bio synthesis. The enzyme FabH 
catalyzes the first step of fatty acid biosynthesis via a type II 
dissociated fatty acid synthase [9-10]. The important role of 
this enzyme in fatty acid biosynthesis and its conservative 
nature made it an attractive target for antitubercular drug 
design and development. Quantitative structure-activity 
relationships (QSAR) are the important methodologies 
in chemo metrics in which mathematical equations were 
generated for correlation of biological activity with structural 
properties. QSAR studies are of different types like 2D, 3D, 4D 
and GQSAR. In 2D QSAR analysis physiochemical properties 
were correlated with the biological potential to identify critical 
physicochemical parameters for optimization. 3D QSAR is 
more advanced than 2D where in 3D properties in terms of 
interactions energies are correlated with bioactivity [11-12]. In 
this research paper we are focused on development of 2D and 
3D-QSAR models for benzoyl amino benzoic acid derivatives 
as Ketoacyl-acyl Carrier Protein Synthase III (FABH) inhibitors.
Computational Methodology
Dataset:
A series of 43 3-phenoxybenzoylamino benzoic acid 
derivatives as β-ketoacyl-acyl carrier protein synthase III 
(FabH) inhibitors reported by Zhe Nieet. al and Ashek et. Al 
[14-16] was utilized to perform the QSAR study. Biological 
activity is expressed in terms of pMIC50 (-log MIC50) was 
utilized as a dependent variable and physicochemical 
parameters in terms of 2D and 3D descriptors are utilized 
as independent variables. Table 1 shows the structure of 43 
selected derivatives along with their biological activity values.
Selection of Training and Test Sets for Models
Selected 3-phenoxybenzoylamino benzoic acid derivatives 
were drawn using 2D sketcher of Vlife engine 4.5. Derivatives 
were further optimized via converting into 3D structures 
keeping native bond angle and bond length intact. Energy 
minimization and geometry optimization of all 43 derivatives 
were carried out using Merck Molecular Force Field. 
Compounds were sketched using the 2D draw application 
and converted to 3D structures. Energy minimization and 
geometry optimization was conducted using Merck molecular 
force field using batch energy minimization method. Dataset 
of all 43 molecules was randomly classified into training set 
(30 molecules) for the development of QSAR model and test 
set (13 molecules) for validation of developed models.
Calculation of 2D and 3D-QSAR Descriptor:
Molecular descriptors are acting as independent variables 
were calculated using QSAR module of V life MDS. Total 
239 2D molecular descriptors were calculated which are 
consist of various physicochemical parameters. Molecular 
alignment is critical step to be followed by calculation of 
the 3D descriptors. Optimized molecules were aligned 
using template-based alignment. 3D field descriptor, were 
calculated using Tripos force field steric, electrostatic and 
hydrophobic field types, having cutoffs of 10.0 and 30.0 kcal/
mol using Gasteiger and Marsilli charges. More than 3000 
3D descriptors were calculated but the invariable descriptors 
were eliminated prior to the QSAR model development.
Model Validation:
Generated QSAR models were validated using standard 
leave one out method. The formula for calculation of cross-
validated r2(q2) value was given in equation 1, where yi and 
ŷi are the actual and predicted activities of the ith molecule, 
respectively and ymean is the average activity of all molecules 
in the training set.
Equation 1:
The predicted r2 (pred_r2) value was calculated using 
equation. 2, where yi and ŷi are the actual and predicted 
activities of the ith molecule, respectively and y mean is the 
average activity of all molecules in the training set.
Equation 2:
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Result and Discussion:
For developing the 2D and 3D QSAR models for 
benzoylamino benzoic acid derivatives as β-ketoacyl-acyl 
carrier protein synthase III (FABH) inhibitors partial least 
square analysis is utilized with stepwise variable selection 
using forward-backward selection algorithm. Statistically 
significant two 2D and 3D QSAR models were generated 
having good internal and external predictive abilities.
Interpretation of 2D QSAR models
2D QSAR model represents the critical physicochemical 
parameters which are having the influence on the biological 
activity of the molecules under study; in simple terms, it is 
the mathematical equation which can be utilized to predict 
biological activity. Here we are reporting two developed 2D 
QSAR model selected on basis of various statistical measures 
obtained from MLR analysis like cross-validated correlation 
coefficient (q2), correlation coefficient (r2) and Fischer 
statistics (F test ) which are indicators of good reliable and 
predictive QSAR model as shown in table 2 and figure 3.
2D QSAR Model A
pIC50 =0.0215+ 0.1743(±0.0911)SaasCcount
+ 0.3141(±0.0867)
XAMostHydrophobicHydrophilicDistance
+ 0.1880(±0.0558)SAMostHydrophobicHydrophilicDistance
-0.0084(±0.0002)XAHydrophilicArea
+ 0.0590(±0.0269)SsOHE-index
-0.1742(±0.1000)SaaNE-index
N = 30 ; r2 = 0.8116; q2 = 0.7122; F test = 30.654; pred r2 = 
0.7181
2D QSAR model A revels some interesting facts about 
the contribution of various descriptors towards FABH 
inhibition. SaasCcount is nothing but the total number 
of carbon connected with one single bond along with two 
aromatic bonds. The positive contribution of SaasCcount 
indicates substitution of aromatic rings with one single bond 
will potentiate the antimicrobial activity of the benzoylamino 
benzoic acid derivatives. XAMost hydrophobic hydrophilic 
distance and SA most hydrophobic hydrophilic distance 
these two descriptors are positively contributing towards 
biological activity, they are signifying distance between most 
hydrophobic and hydrophilic point on the vdW surface 
calculated by kellong method and distance between most 
hydrophobic and hydrophilic point on the vdW surface 
calculated by audry method using Slogp. The positive 
contribution of these two descriptors indicates increment 
in the hydrophobic surface area will lead to increase in 
antifungal activity.XAHydrophilicArea is another descriptor 
contributing negatively towards the antifungal activity 
which signifies vdW surface descriptor showing hydrophilic 
surface. Reduction in the polar surface area of benzoylamino 
benzoic acid derivatives will potentiate antimicrobial 
activity. SsOHE-index is topological descriptor contributing 
positively toward antimicrobial activity,SsOHE-index is an 
electron topological state indices for a number of –OH group 
connected with one single bond. Positive contribution of 
SsOHE-index indicates substitution of the hydroxyl group on 
benzoylamino benzoic acid skeletal will potentiate antifungal 
activity.SaaNE-index is the electrotopological state indices 
for a number of nitrogen atom connected with two aromatic 
bonds, negative contribution of this descriptor indicates 
the reduction in the nitrogen substitution will potentiate 
antimicrobial activity.
2D QSAR Model B
pIC50 = 1.8242+ 0.8670(±0.1440)6ChainCount
+ 0.0776(±0.0182)SsOHE-index
+ 0.1849(±0.0542)SAMostHydrophobicHydrophilicDistance
-0.0401(±0.0013)XAHydrophilicArea
-0.0313(±0.0015) SAHydrophilicArea
-0.0856(±0.0240)SssOE-index
N = 30; r2 = 0.7421; q2 = 0:6821; F test = 21.654; pred r2 = 
0.6182
2D QSAR model B is another generated model which 
indicates the positive contribution of descriptors like 
6ChainCount, SsOHE-index and SAMost hydrophobic 
hydrophilic distance and negative contribution of 
XAHydrophilicArea, SAHydrophilicArea and SssOE-index. 
6ChainCount is a topological descriptor indicating total 
number six-membered rings in a compound, while SssOE-
index is electro-topological descriptor for number of oxygen 
atom connected with two single bonds.
Interpretation of 3D QSAR models
3D QSAR model represents the critical conformation 
attributes like electrostatic, steric and hydrophobic which 
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are affecting the antimicrobial potential of molecules under 
study. Here we are reporting two developed 3D QSAR model 
selected on basis of various statistical measures obtained 
from PLS analysis like cross-validated correlation coefficient 
(q2), correlation coefficient (r2) and Fischer statistics (F test 
) which are indicators of good reliable and predictive QSAR 
model as shown in table 2.
3D QSAR Model C
pIC50 = 5.4024+ 0.0470S_989
+0.4348S_141
+0.0487S_614
+0.1804 E_899
+0.0760 E_444
+0.2222 E_853
N = 30; r2 = 0.8972; q2 = 0.6296; F test = 28.654; pred r2 = 
0.7362
QSAR Model C explains Electrostatic and steric requirement 
for 3-phenoxybenzoylamino benzoic acid derivatives to act 
as FABH inhibitor. Negative contribution of E_899indicates 
the reduction of electrostatic interactions is favored in that 
region; the substitution of the electron with drawing groups 
like nitro will potentiate the antimicrobial activity. The 
positive contribution of S_989, S_141 and S_614 indicates 
the increase in the lipophilic nature of the molecules will 
lead to increase in the antimicrobial activity. Increased 
lipophilic nature of the molecules may be responsible 
for permeation through the cell wall of the organisms. 
Electrostatic interactions at the grid point E_899, E_444and 
E_853are positively contributing which indicates critical 
role of substitution of electron releasing groups which will 
potentiate the delocalization of the electron in the ring 
system as shown in figure 1 and figure 4
3D QSAR Model D
pIC50 = 5.7340 +0.1882S_149
+0.0433S_989
-0.0306S_710
-0.0411E_917
-0.0411S_452
+0.0698E_902
N = 30; r2 = 0.8114; q2 = 0.6161; F test = 26.882; pred r2 = 
0.4184
QSAR D is another generated 3D QSAR model for 
prediction of antimicrobial potential of selected 
3-phenoxybenzoylamino benzoic acid derivatives to act 
as FABH inhibitor. Applicability of this QSAR model is 
limited due lower correlation coefficient and other statistical 
measures in compares with 3D QSAR model C. QSAR model 
D signifies positive contribution of S_149, S_989 and E_902, 
while negative contribution of S_710, E_917 and S_452 as 
shown in figure 2
Conclusion
In this communication, we have successfully employed 2D and 
3DQSAR models forbenzoylamino benzoic acid derivatives 
as β-Ketoacyl-acyl Carrier Protein Synthase III (FABH) 
inhibitors. The results revealed that generated QSAR model 
are having high degree of predictivity, which indicates these 
models can be successfully employed for the development 
of FABH inhibitors. Generated QSAR model indicated the 
importance of lipophilic parameters in FABH inhibition by 
benzoylamino benzoic acid derivatives. Furthermore, in the 
presence of electronegative groups are also having the critical 
influence on the antimicrobial activity. Furthermore, this 
theoretical study will give valuable inputs for development 
for novel FABH inhibitors.
Subramani et al.
2D and 3D-QSAR models for benzoyl amino benzoic acid derivatives as FABH inhibitorsMarmara Pharm J 21/3: 631-643, 2017 635
Table 1. Table showing Molecules under study
N
H
O
OH O
R4
R2
R1
R3
Sr. No. R1 R2 R3 R4 Observed activity
1. F H
S
N
O
O
H
5.08
2. Br H
S
N
O
O
H
5.8
3. Ph H
S
N
O
O
H
5.8
4. Br Me
S
N
O
O
H
3.8
5. OMe H
S
N
O
O
H
4.94
6.
N
H
S
N
O
O
H
5.66
7. O H
S
N
O
O
H
5.21
8.
O
H
S
N
O
O
H
5.68
9. H H
O
H
5.57
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10. F H
O
H
5.42
11. Br H
O
H
4.96
12.
N
N
H
O
H
4.6
13.
N
NH
H
O
H
4.42
14.
N
O
H
O
H
5.49
15.
N
S
H
O
H
5.92
16.
N
H
O
H
6.54
17.
N
H
O
H
6.57
18.
N
N
H H O
H
4.66
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19.
N
H
O
H
6.96
20. H
O
H
7.25
21. Br H
O
OH
7.21
N
H
O
OH O
R2
O
Sr. no R1 R2 Observed activity
22. CF3 H 7.02
23. Me H 6.8
24. CO2H H 5.68
25. OH H 6.39
26. OEt H 6.66
27. SO2Me H 7.55
28. OCF3 H 6.33
29. iPr H 6.1
30. 3-Me-4-F H 6.62
31. 2,4-di-F H 6.8
32. 3,4-di-F H 6.48
33. 3-Me-4-Cl H 6.6
34. 3-Cl-4-F H 6.24
35. H OH 8.4
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N
H
O
OH O
O
A
B
C
Sr. No. A C Observed activity
36.
S
Ph
5
37.
S
Ph
4.37
38.
F
Ph
5.22
39.
OH
Ph
6.39
40. Ph 4-Pyr 5
41. Ph 3-CO2H-Ph 5.43
42. Ph 4-CO2H-Ph 5.36
43. Ph 4-F-Ph 5.3
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Table 2. Observed and predicted activity
Molecule No Observed Activity Predicted Activity
2D QSAR A 2D QSAR B 3D QSAR C 3D QSAR D
1. 5.0 5.2 5.1 5.3 4.8
2. 5.8 5.6 4.6 5. 5.0
3. 5.8 5.7 5.1 6.7 6.8
4. 3.8 3.5 4.5 4.8 3.8
5. 4.9 4.9 4.9 6.3 4.7
6. 5.6 5.8 5.7 5.8 5.9
7.* 5.2 5.2 5.3 5.9 5.2
8.* 5.6 5.6 5.7 5.4 5.8
9. 5.5 5.7 5.5 5.4 5.3
10.* 5.4 5.3 5.5 6.5 5.5
11.* 4.9 5.8 5.5 5.3 5.4
12. 4.6 4.9 4.7 6.6 4.6
13. 4.4 4.3 4.5 7.3 5.4
14. 5.4 5.6 5.9 6.9 5.3
15. 5.9 6.0 6.2 6.4 5.1
16. 6.5 6.8 6.4 6.2 6.4
17. 6.5 6.7 6.2 6.5 6.0
18.* 4.6 5.2 4.6 6.6 4.8
19.* 6.9 6.5 6.4 7.5 6.2
20.* 7.2 6.9 6.4 6.5 6.2
21. 7.2 7.1 6.2 6.1 6.6
22. 7.0 6.6 6.7 5.3 6.1
23. 6.8 6.6 6.6 6.3 6.7
24. 5.6 5.5 6.6 6.1 6.5
25. 6.3 6.2 6.2 6.1 6.3
26.* 6.6 6.5 6.2 6.5 6.2
27. 7.5 7.6 5.7 6.2 6.4
28. 6.3 6.5 6.4 9.4 5.8
29. 6.1 6.9 6.5 5.2 6.2
30. 6.6 6.7 6.7 4.5 6.6
31.* 6.8 6.3 6.5 5.6 7.4
32.* 6.4 6.2 6.4 5.7 6.6
33. 6.6 6.5 6.6 5.9 6.4
34. 6.2 6.7 6.9 5.1 6.5
35.* 8.4 7.8 7.1 5.1 8.6
36.* 5 5.2 4.6 5.5 5.4
37.* 4.3 4.3 5.0 5.6 5.7
38. 5.2 5.1 5.3 3.8 5.5
39. 6.3 6.2 6.1 4.7 5.7
40. 5 5.4 5.7 5.8 5.0
41. 5.4 5.2 5.4 6.1 5.2
42. 5.3 4.9 5.6 5.5 5.3
43. 5.3 5.8 5.8 4.8 5.5
*: test set molecules
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Table 3. Correlation Matrix for 2D QSAR Model A
Saas
Ccount
XAMost
Hydrophobic
Hydrophilic
Distance
SAMost
hydrophobic
Hydrophilic
Distance
XA
Hydrophilic
Area
SsOHE-
index SaaNE-index
SaasCcount 1 0.442 0.524 -0.253 0.042 0.097
XAMost
Hydrophobic
HydrophilicDistance 0.442 1 0.042 0.403 -0.159 -0.066
SAMost
Hydrophobic
HydrophilicDistance 0.524 0.042 1 -0.64 0.197 -0.096
XA
HydrophilicArea -0.253 0.403 -0.64 1 -0.179 -0.054
SsOHE-index 0.042 -0.159 0.197 -0.179 1 -0.116
SaaNE-index 0.097 -0.066 -0.096 -0.054 -0.116 1
Table 4. Correlation Matrix for 2D QSAR Model B
6Chain
Count
SsOHE-
index
SAMost
Hydrophobic
Hydrophilic
Distance
XAHydrophilic
Area
SAHydrophilic
Area SssOE-index
6ChainCount 1 0.442 0.524 -0.253 0.042 0.097
SsOHE-index 0.442 1 0.042 0.403 -0.159 -0.066
SAMostHydrophobic
HydrophilicDistance 0.524 0.042 1 -0.64 0.197 -0.096
XA
HydrophilicArea -0.253 0.403 -0.64 1 -0.179 -0.054
SA
HydrophilicArea 0.042 -0.159 0.197 -0.179 1 -0.116
SssOE-index 0.097 -0.066 -0.096 -0.054 -0.116 1
Table 5. Table showing Correlation Matrix For 3D QSAR Model C
S_989 S_141 S-614 E_899 E_444 E_853
S_989 1 0.324 0.125 0.003 0.233 0.017
S_141 0.234 1 0.126 -0.009 -0.083 -0.05
S-614 0.156 0.089 1 -0.10 0.1 -0.003
E_899 0.082 -0.005 -0.349 1 -0.005 0.083
E_444 0.156 -0.073 0.1 -0.075 1 0.214
E_853 0.009 -0.13 -0.033 0.093 0.034 1
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Table 6. Correlation Matrix For 3D QSAR Model D
E_917 E_902 S_149 S_710 S_452 S_989
E_917 1 0.086 -0.228 -0.496 -0.277 0.136
E_902 0.086 1 -0.094 -0.153 -0.232 0.053
S_149 -0.228 -0.094 1 0.256 0.307 0.051
S_710 -0.496 -0.153 0.256 1 0.385 0.189
S_452 -0.277 -0.232 0.307 0.385 1 -0.018
S_989 0.136 0.053 0.051 0.189 -0.018 1
Figure 1. Field point of QSAR model C
Figure 2. Field point of QSAR model D
Subramani et al.
2D and 3D-QSAR models for benzoyl amino benzoic acid derivatives as FABH inhibitors Marmara Pharm J 21/3: 631-643, 2017642
Figure 3. Correlation plot for QSAR model A
Figure 4. Correlation plot for QSAR model C
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